Page last updated: 2024-09-04

neferine and benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone

neferine has been researched along with benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone in 1 studies

Compound Research Comparison

Studies
(neferine)
Trials
(neferine)
Recent Studies (post-2010)
(neferine)
Studies
(benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone)
Trials
(benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone)
Recent Studies (post-2010) (benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone)
16501201,8970411

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
An, L; Jiang, Y; Liu, CM; Pan, B; Wu, Z; Zhou, J; Zhu, C1

Other Studies

1 other study(ies) available for neferine and benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone

ArticleYear
The antiandrogenic effect of neferine, liensinine, and isoliensinine by inhibiting 5-α-reductase and androgen receptor expression via PI3K/AKT signaling pathway in prostate cancer.
    Die Pharmazie, 2021, 05-01, Volume: 76, Issue:5

    Topics: 5-alpha Reductase Inhibitors; Amino Acid Chloromethyl Ketones; Androgen Antagonists; Androgen Receptor Antagonists; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Benzylisoquinolines; Biological Products; Cell Line, Tumor; Cell Movement; Chromones; Heterocyclic Compounds, 3-Ring; Humans; Isoquinolines; Male; Morpholines; Nelumbo; Phenols; Phosphatidylinositol 3-Kinases; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Signal Transduction

2021